Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.

about

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.

Item

http://www.wikidata.org/entity/Q52777337

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@en

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@nl

type

Item

label

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@en

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@nl

prefLabel

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@en

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@nl

P1476

Evaluation of Posaconazole Pha ...... ith Invasive Fungal Infection.

@en

P2093

Amedeo De Nicolò

http://www.w3.org/2001/XMLSchema#string

Chiara Carcieri

http://www.w3.org/2001/XMLSchema#string

Elisa Pirro

http://www.w3.org/2001/XMLSchema#string

Fabio Favata

http://www.w3.org/2001/XMLSchema#string

Giovanna Fatiguso

http://www.w3.org/2001/XMLSchema#string

Giovanni Di Perri

http://www.w3.org/2001/XMLSchema#string

Jessica Cusato

http://www.w3.org/2001/XMLSchema#string

Silvia De Francia

http://www.w3.org/2001/XMLSchema#string

P2860

Hidden killers: human fungal infections

Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation

Gender differences in pharmacokinetics and pharmacodynamics.

Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.

Systemic mycoses in the immunocompromised host: an update in antifungal therapy.

Voriconazole.

A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?

Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.

P31

scholarly article

P356

10.3390/BIOMEDICINES5040066

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio D'Avolio

Sarah Allegra

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29156624

http://www.w3.org/2001/XMLSchema#string

P932

5744090

http://www.w3.org/2001/XMLSchema#string